ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2025 ANS Winter Conference & Expo
November 9–12, 2025
Washington, DC|Washington Hilton
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Sep 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
Fusion Science and Technology
October 2025
Latest News
NN Asks: What did you learn from ANS’s Nuclear 101?
Mike Harkin
When ANS first announced its new Nuclear 101 certificate course, I was excited. This felt like a course tailor-made for me, a transplant into the commercial nuclear world. I enrolled for the inaugural session held in November 2024, knowing it was going to be hard (this is nuclear power, of course)—but I had been working on ramping up my knowledge base for the past year, through both my employer and at a local college.
The course was a fast-and-furious roller-coaster ride through all the key components of the nuclear power industry, in one highly challenging week. In fact, the challenges the students experienced caught even the instructors by surprise. Thankfully, the shared intellectual stretch we students all felt helped us band together to push through to the end.
We were all impressed with the quality of the instructors, who are some of the top experts in the field. We appreciated not only their knowledge base but their support whenever someone struggled to understand a concept.
Jonas D. Fontenot, Phillip Taddei, Yuanshui Zheng, Dragan Mirkovic, Wayne D. Newhauser
Nuclear Technology | Volume 168 | Number 1 | October 2009 | Pages 173-177
Dose/Dose Rate | Special Issue on the 11th International Conference on Radiation Shielding and the 15th Topical Meeting of the Radiation Protection and Shielding Division (Part 1) / Radiation Protection | doi.org/10.13182/NT09-A9121
Articles are hosted by Taylor and Francis Online.
The purpose of this study was to evaluate the suitability of the quantity ambient dose equivalent H*(10) as a conservative estimate of effective dose E for estimating stray radiation exposures to patients receiving passively scattered proton radiotherapy for cancer of the prostate. H*(10), which is determined from fluence free-in-air, is potentially useful because it is simpler to measure or calculate because it avoids the complexities associated with phantoms or patient anatomy. However, the suitability of H*(10) as a surrogate for E has not been demonstrated for exposures to high-energy neutrons emanating from radiation treatments with proton beams. The suitability was tested by calculating H*(10) and E for a proton treatment using a Monte Carlo model of a double-scattering treatment machine and a computerized anthropomorphic phantom. The calculated E for the simulated treatment was 5.5 mSv/Gy, while the calculated H*(10) at the isocenter was 10 mSv/Gy. A sensitivity analysis revealed that H*(10) conservatively estimated E for the interval of treatment parameters common in proton therapy for prostate cancer. However, sensitivity analysis of a broader interval of parameters suggested that H*(10) may underestimate E for treatments of other sites, particularly those that require large field sizes. Simulations revealed that while E was predominated by neutrons generated in the nozzle, neutrons produced in the patient contributed up to 40% to dose equivalent in near-field organs.
